Loading clinical trials...
Loading clinical trials...
An Evaluation of the Pharmacokinetics and Safety of a Single Dose of UT-15C SR (Treprostinil Diethanolamine) in Subjects With Renal Impairment.
Conditions
Interventions
UT-15C SR (treprostinil diethanolamine)
Locations
1
United States
Orlando Clinical Research Center
Orlando, Florida, United States
Start Date
May 1, 2010
Primary Completion Date
September 1, 2010
Completion Date
September 1, 2010
Last Updated
May 17, 2012
NCT06649110
NCT07218029
NCT06481852
NCT01347216
NCT05464095
NCT07090512
Lead Sponsor
United Therapeutics
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions